GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Gencurix Inc (XKRX:229000) » Definitions » Purchase Of Investment

Gencurix (XKRX:229000) Purchase Of Investment : ₩-10,200 Mil (TTM As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Gencurix Purchase Of Investment?

Gencurix's purchase of investment for the three months ended in Mar. 2024 was ₩0 Mil. It means Gencurix spent ₩0 Mil on purchasing investments. Gencurix's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-10,200 Mil.

Compared with last quarter (₩-7,000 Mil in Dec. 2023 ), Gencurix spent less money on purchasing investments in Mar. 2024 (₩0 Mil).


Gencurix Purchase Of Investment Historical Data

The historical data trend for Gencurix's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gencurix Purchase Of Investment Chart

Gencurix Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Investment
Get a 7-Day Free Trial -54.80 -524.80 -10,000.00 - -10,200.00

Gencurix Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -200.00 -6,500.00 3,500.00 -7,000.00 -

Gencurix Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-10,200 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gencurix Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Gencurix's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Gencurix (XKRX:229000) Business Description

Traded in Other Exchanges
N/A
Address
9th Floor, Hanhwa Bizmetro I, Guro 3-dong, Guro-gu, Seoul, KOR, 152-733
Gencurix Inc develops diagnosis treatment kits. It offers products including GenesWell BCT, a breast cancer test; GenesWell ddEGFR Mutation Test; GenesWell CDx EGFR Mutation Test; and GenesWell ddEGFR mutation Test.

Gencurix (XKRX:229000) Headlines

No Headlines